Terrence William Pizzie
Chief Executive Officer chez Astrea Bioseparations Ltd.
Postes actifs de Terrence William Pizzie
Sociétés | Poste | Début | Fin |
---|---|---|---|
Astrea Bioseparations Ltd.
Astrea Bioseparations Ltd. Medical SpecialtiesHealth Technology Astrea Bioseparations Ltd. develops and manufactures affinity purification technology. It specializes in affinity chromatography and bioseparations, specifically purification of proteins and the elimination of contaminants including pathogens. The company was founded in 1987 and is headquartered in Cambridge, the United Kingdom. | Chief Executive Officer | 14/06/2021 | - |
Historique de carrière de Terrence William Pizzie
Anciens postes connus de Terrence William Pizzie
Sociétés | Poste | Début | Fin |
---|---|---|---|
Genetix Group Ltd.
Genetix Group Ltd. Medical SpecialtiesHealth Technology Genetix Group Ltd. provides scientists and clinicians with unrivalled solutions for imaging and intelligent image analysis. The company operates research, pharmaceutical and biotherapeutic developments. Its product brands include ClonePix, Clone Pix FL, Clone Select Imager, Clone Fill, Cell Dispense, QP Expression, QP Display, QP Interactor, OP Evolution, Q Select, O Pix2 XT, O Pix2, MegaPix, QBot, gelPix, gloPix, Q ArrayMini, Q Array2, Q ArrayMax, aliQuot, Q Fill and Mega Pix. Genetix was founded by Mark Reid in 1991 and is headquartered in New Milton, the United Kingdom. | Director/Board Member | - | 14/01/2010 |
Corporate Officer/Principal | 01/09/2007 | 14/01/2010 | |
Pacific Biosciences UK Ltd. | Sales & Marketing | - | - |
Biacore AB | Corporate Officer/Principal | 01/01/2005 | - |
Applied Biosystems Ltd. | Corporate Officer/Principal | 01/01/1988 | - |
HORIZON DISCOVERY GROUP PLC | Director/Board Member | 08/05/2018 | - |
Chief Executive Officer | 08/05/2018 | - | |
Corporate Officer/Principal | 01/02/2017 | 08/05/2018 |
Formation de Terrence William Pizzie
The University of Reading | Undergraduate Degree |
Statistiques
Internationale
Royaume-Uni | 7 |
Suède | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 6 |
---|---|
Genetix Group Ltd.
Genetix Group Ltd. Medical SpecialtiesHealth Technology Genetix Group Ltd. provides scientists and clinicians with unrivalled solutions for imaging and intelligent image analysis. The company operates research, pharmaceutical and biotherapeutic developments. Its product brands include ClonePix, Clone Pix FL, Clone Select Imager, Clone Fill, Cell Dispense, QP Expression, QP Display, QP Interactor, OP Evolution, Q Select, O Pix2 XT, O Pix2, MegaPix, QBot, gelPix, gloPix, Q ArrayMini, Q Array2, Q ArrayMax, aliQuot, Q Fill and Mega Pix. Genetix was founded by Mark Reid in 1991 and is headquartered in New Milton, the United Kingdom. | Health Technology |
Astrea Bioseparations Ltd.
Astrea Bioseparations Ltd. Medical SpecialtiesHealth Technology Astrea Bioseparations Ltd. develops and manufactures affinity purification technology. It specializes in affinity chromatography and bioseparations, specifically purification of proteins and the elimination of contaminants including pathogens. The company was founded in 1987 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Biacore AB | |
Applied Biosystems Ltd. | |
Horizon Discovery Group Ltd.
Horizon Discovery Group Ltd. Medical SpecialtiesHealth Technology Horizon Discovery Group Ltd. is a cell engineering company, which engages in the design and engineering of genetically-modified cells. The firm operates through the following business segments: Products, Services, and Leveraged Research & Development. The Products segment sells cell lines and other products. The Services segment offers cell line manufacturing services. The Leveraged Research & Development segment business unit is operated on a portfolio basis. It serves pharmaceutical, biotechnology, and diagnostic companies. The company was founded by Christopher John Torrance, Adam John Collier, and Alberto Bardelli in July 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Pacific Biosciences UK Ltd. |
- Bourse
- Insiders
- Terrence William Pizzie
- Expérience